Literature DB >> 18379240

Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery.

Julien Amour1, Aurélie Birenbaum, Olivier Langeron, Yannick Le Manach, Michèle Bertrand, Pierre Coriat, Bruno Riou, Maguy Bernard, Pierre Hausfater.   

Abstract

OBJECTIVE: Procalcitonin has been advocated as a specific biomarker for bacterial infection. We performed this study to determine whether accuracy of procalcitonin for diagnosis of postoperative bacterial infection is affected by renal function after aortic surgery.
DESIGN: Single-center prospective study.
SETTING: University hospital. PATIENTS: Two hundred seventy-six patients scheduled for elective major aortic surgery.
INTERVENTIONS: Blood samples were taken before surgery and each day over the 5-day postoperative period, and measurement of serum procalcitonin was performed. Diagnosis of infection was performed by a blinded expert panel. Renal function was assessed using an estimate of creatinine clearance with the Cockcroft formulas. Renal dysfunction was defined as a creatinine clearance <50 mL x min(-1).
MEASUREMENTS AND MAIN RESULTS: Infection was diagnosed in 67 patients. Seventy five patients (27%) had postoperative renal dysfunction. Procalcitonin was significantly higher in infected patients, with a peak reached at the fourth postoperative day, but it was significantly higher in patients with impaired renal function in both control and infected patients. The optimal threshold of procalcitonin markedly differed in patients with renal dysfunction compared with patients without renal dysfunction (2.57 vs. 0.80 ng x mL(-1), p < .05). The diagnostic accuracy of procalcitonin significantly increased (0.74 vs. 0.70, p < .05) when the threshold of procalcitonin was adapted to the renal function. The elevation of procalcitonin occurred 2 days before the medical team was able to diagnose infection.
CONCLUSIONS: Procalcitonin is a valuable marker of bacterial infections after major aortic surgery, but renal function is a major determinant of procalcitonin levels and thus different thresholds should be applied according to renal function impairment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379240     DOI: 10.1097/CCM.0b013e3181692966

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  27 in total

1.  Microbial diagnostics in patients with presumed severe infection in the emergency department.

Authors:  S Hettwer; J Wilhelm; M Schürmann; H Ebelt; D Hammer; M Amoury; F Hofmann; A Oehme; D Wilhelms; A S Kekulé; T Klöss; K Werdan
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02       Impact factor: 0.840

2.  Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients.

Authors:  Raluca Dumea; Dimitrie Siriopol; Simona Hogas; Irina Mititiuc; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2013-08-30       Impact factor: 2.370

Review 3.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

4.  Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.

Authors:  Yanbei Sun; Lijuan Jiang; Xiaonan Shao
Journal:  Int Urol Nephrol       Date:  2017-09-27       Impact factor: 2.370

Review 5.  Procalcitonin-guided antibiotic treatment in critically ill patients.

Authors:  Andreas Hohn; Bernhard Heising; Jan-Karl Schütte; Olaf Schroeder; Stefan Schröder
Journal:  Langenbecks Arch Surg       Date:  2016-06-10       Impact factor: 3.445

6.  The effect of local anesthetic continuous wound infusion for the prevention of postoperative pneumonia after on-pump cardiac surgery with sternotomy: the STERNOCAT randomized clinical trial.

Authors:  Julien Amour; Bernard Cholley; Alexandre Ouattara; Dan Longrois; Pascal Leprince; Jean-Luc Fellahi; Bruno Riou; Sarah Hariri; Christian Latrémouille; Alain Rémy; Sophie Provenchère; Aude Carillion; Paul Achouh; Louis Labrousse; Alexy Tran Dinh; Nora Ait Hamou; Ahmed Charfeddine; Alexandre Lafourcade; David Hajage; Adrien Bouglé
Journal:  Intensive Care Med       Date:  2019-01-07       Impact factor: 17.440

Review 7.  Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Authors:  Mirjam Christ-Crain; Steven M Opal
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

8.  Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients.

Authors:  Nicolas Mongardon; Virginie Lemiale; Sébastien Perbet; Florence Dumas; Stéphane Legriel; Sylvie Guérin; Julien Charpentier; Jean-Daniel Chiche; Jean-Paul Mira; Alain Cariou
Journal:  Intensive Care Med       Date:  2009-10-21       Impact factor: 17.440

9.  Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome.

Authors:  Pierre Emmanuel Charles; Claire Tinel; Saber Barbar; Serge Aho; Sébastien Prin; Jean Marc Doise; Nils Olivier Olsson; Bernard Blettery; Jean Pierre Quenot
Journal:  Crit Care       Date:  2009-03-16       Impact factor: 9.097

10.  Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report.

Authors:  Pierre Emmanuel Charles; Emmanuel Kus; Serge Aho; Sébastien Prin; Jean-Marc Doise; Nils-Olivier Olsson; Bernard Blettery; Jean-Pierre Quenot
Journal:  BMC Infect Dis       Date:  2009-04-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.